Annual ROE
139.22%
+397.23%+153.96%
31 December 2023
Summary:
FibroGen annual return on equity is currently 139.22%, with the most recent change of +397.23% (+153.96%) on 31 December 2023. During the last 3 years, it has risen by +177.98% (+459.18%). FGEN annual ROE is now at all-time high.FGEN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
53.64%
-28.29%-34.53%
30 September 2024
Summary:
FibroGen quarterly return on equity is currently 53.64%, with the most recent change of -28.29% (-34.53%) on 30 September 2024. Over the past year, it has dropped by -303.21% (-84.97%). FGEN quarterly ROE is now -84.97% below its all-time high of 356.85%, reached on 30 September 2023.FGEN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FGEN ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +154.0% | -85.0% |
3 y3 years | +459.2% | +196.4% |
5 y5 years | +966.9% | +610.5% |
FGEN ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +154.0% | -85.0% | +102.6% |
5 y | 5 years | at high | +154.0% | -85.0% | +102.6% |
alltime | all time | at high | +154.0% | -85.0% | +102.6% |
FibroGen ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 53.64%(-34.5%) |
June 2024 | - | 81.93%(-41.1%) |
Mar 2024 | - | 139.05%(-37.3%) |
Dec 2023 | 139.22%(-154.0%) | 221.86%(-37.8%) |
Sept 2023 | - | 356.85%(-117.6%) |
June 2023 | - | -2030.36%(+320.0%) |
Mar 2023 | - | -483.45%(+89.5%) |
Dec 2022 | -258.01%(+198.3%) | -255.06%(+30.1%) |
Sept 2022 | - | -196.03%(+105.9%) |
June 2022 | - | -95.22%(-3.8%) |
Mar 2022 | - | -98.95%(+15.0%) |
Dec 2021 | -86.50%(+123.2%) | -86.02%(+54.5%) |
Sept 2021 | - | -55.66%(-3.9%) |
June 2021 | - | -57.91%(+39.2%) |
Mar 2021 | - | -41.61%(+2.9%) |
Dec 2020 | -38.76%(+167.9%) | -40.44%(-11.2%) |
Sept 2020 | - | -45.52%(-21.3%) |
June 2020 | - | -57.84%(+193.0%) |
Mar 2020 | - | -19.74%(+45.4%) |
Dec 2019 | -14.47% | -13.58%(-279.9%) |
Sept 2019 | - | 7.55%(-17.0%) |
June 2019 | - | 9.10%(-151.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | -17.66%(+6.3%) |
Dec 2018 | -16.06%(-52.0%) | -16.62%(-37.4%) |
Sept 2018 | - | -26.53%(+4.3%) |
June 2018 | - | -25.43%(-20.5%) |
Mar 2018 | - | -31.99%(-9.3%) |
Dec 2017 | -33.44%(+7.1%) | -35.26%(-18.1%) |
Sept 2017 | - | -43.03%(-27.6%) |
June 2017 | - | -59.40%(+78.2%) |
Mar 2017 | - | -33.34%(+10.0%) |
Dec 2016 | -31.22%(-20.4%) | -30.30%(-21.8%) |
Sept 2016 | - | -38.76%(-15.1%) |
June 2016 | - | -45.66%(+47.5%) |
Mar 2016 | - | -30.95%(-17.0%) |
Dec 2015 | -39.21%(+14.7%) | -37.27%(-6.7%) |
Sept 2015 | - | -39.94%(-2.7%) |
June 2015 | - | -41.06%(-26.5%) |
Mar 2015 | - | -55.90%(+40.4%) |
Dec 2014 | -34.17%(+162.6%) | -39.82%(+32.7%) |
Sept 2014 | - | -30.00%(-166.7%) |
June 2014 | - | 44.98%(-1067.3%) |
Mar 2014 | - | -4.65%(-129.6%) |
Dec 2013 | -13.01%(-62.3%) | 15.72% |
Dec 2012 | -34.47% | - |
FAQ
- What is FibroGen annual return on equity?
- What is the all time high annual ROE for FibroGen?
- What is FibroGen annual ROE year-on-year change?
- What is FibroGen quarterly return on equity?
- What is the all time high quarterly ROE for FibroGen?
- What is FibroGen quarterly ROE year-on-year change?
What is FibroGen annual return on equity?
The current annual ROE of FGEN is 139.22%
What is the all time high annual ROE for FibroGen?
FibroGen all-time high annual return on equity is 139.22%
What is FibroGen annual ROE year-on-year change?
Over the past year, FGEN annual return on equity has changed by +397.23% (+153.96%)
What is FibroGen quarterly return on equity?
The current quarterly ROE of FGEN is 53.64%
What is the all time high quarterly ROE for FibroGen?
FibroGen all-time high quarterly return on equity is 356.85%
What is FibroGen quarterly ROE year-on-year change?
Over the past year, FGEN quarterly return on equity has changed by -303.21% (-84.97%)